Holen Sie sich die Stockscreener-App
485.36
1.30%
-6.10
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$491.46
Offen:
$492
24-Stunden-Volumen:
765.91K
Relative Volume:
0.33
Marktkapitalisierung:
$180.22B
Einnahmen:
$44.56B
Nettoeinkommen (Verlust:
$6.72B
KGV:
27.36
EPS:
17.7387
Netto-Cashflow:
$6.29B
1W Leistung:
+1.05%
1M Leistung:
-3.36%
6M Leistung:
-10.82%
1J Leistung:
+10.77%
1-Tages-Spanne:
$479.95
$493.33
1-Wochen-Bereich:
$479.65
$506.82
52-Wochen-Spanne:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
485.13 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.80 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
575.96 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.14 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.06 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | DZ Bank | Buy |
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Thermo Fisher Scientific Inc. $TMO Shares Sold by Rathbones Group PLC - MarketBeat
JB Capital LLC Decreases Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Perpetual Ltd Has $157.65 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. (TMO) stock price, news, quote and history - Yahoo Finance Singapore
Thermo Fisher Scientific introduces Gibco™ CTS™ Compleo™ Fill and Finish System - biospectrumasia.com
Is Thermo Fisher Scientific (TMO) one of the best conservative stocks to buy right now? - MSN
Molecular Diagnostics Market Size is Expected to Reach USD 43.50 Billion by 2035 Owing to the Surging Demand for Accurate and Early Disease Detection Globally | SNS Insider - GlobeNewswire Inc.
Aberdeen Group plc Grows Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Introduces Gibco Cts Compleo Fill and Finish System - MarketScreener
Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing - Business Wire
Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching - Yahoo Finance
TMO Stock May Gain From the Rollout of Gibco CHOvantage GS CLD Kit - TradingView
Exosome Research Market is Thriving Worldwide | Thermo Fisher Scientific, Illumina Inc, Miltenyi Biotec, QIAGEN - openPR.com
Compagnie Lombard Odier SCmA Buys 5,895 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Launches Integrated Platform to Accelerate Biologics Development - Business Wire
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026 - PharmiWeb.com
Smarter Raman QC for biopharma fill-finish with scalable model transfer - European Pharmaceutical Review
Live Cell Imaging Market Set to Boom Rapidly by 2033| Thermo Fisher Scientific Inc. • Merck KgaA • PerkinElmer Inc - openPR.com
Scharf Investments LLC Sells 10,342 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Rockland Trust Co. Has $34.27 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
List of 54 Acquisitions by Thermo Fisher Scientific (Apr 2026) - Tracxn
[Form 4] THERMO FISHER SCIENTIFIC INC. Insider Trading Activity - Stock Titan
Thermo Fisher (NYSE: TMO) director receives 66 Phantom Stock Units as deferred pay - Stock Titan
Thermo Fisher (NYSE: TMO) director granted 66.02 phantom stock units - Stock Titan
Thermo Fisher (NYSE: TMO) director adds 66 Phantom Stock Units under deferred plan - Stock Titan
Thermo Fisher (NYSE: TMO) director adds phantom stock units grant - Stock Titan
Thermo Fisher Scientific Stock: Leading Life Sciences Provider Faces Mixed Institutional Flows Amid - AD HOC NEWS
Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM - The Joplin Globe
Northstar Advisory Group LLC Acquires Shares of 5,609 Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Position Trimmed by James Hambro & Partners LLP - MarketBeat
J. Safra Sarasin Holding AG Lowers Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Mn Services Vermogensbeheer B.V. Has $84.72 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
How is Thermo Fisher (TMO) Preparing to Deal With Rising Helium Prices - Insider Monkey
Thermo Fisher Scientific Inc. stock rises Monday, outperforms market - MarketWatch
Thermo Fisher Scientific Stock Hits Day Low Amid Price Pressure at $472.08 - Markets Mojo
Thermo Fisher Scientific (TMO) Sets Stage for Q4 Rally with Impressive Q3 Earnings and New 52-Week High - Insider Monkey
U.S. Automated Analyzer Market Is Going to Boom| Thermo Fisher - openPR.com
Thermo Fisher (TMO) Shares Up Since Jim Cramer Called the Firm “Unbelievable” - Insider Monkey
Food Testing Kits Market Is Going to Boom | Thermo Fisher Scientific • Eurofins Scientific • SGS SA - openpr.com
Wedge Capital Management L L P NC Sells 6,634 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Canoe Financial LP Decreases Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Assenagon Asset Management S.A. Has $6.22 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Generate Investment Management Ltd Has $20.66 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Shares Sold by DAVENPORT & Co LLC - National Today
Eagle Rock Investment Company LLC Boosts Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by DAVENPORT & Co LLC - MarketBeat
New Platform Boosts Injectable Drug Manufacturing - Technology Networks
Thermo Fisher Scientific Inc. (NYSE:TMO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Thermo Fisher Scientific Inc Stock (TMO) Moved Down by 3.31% on Mar 27: What Investors Need To Know - TradingKey
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.28%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):